Fundraising Fox
Samit Hirawat
InvestorStrategic Medical Advisor at Jeito Capital
Find your path to Samit
Sign up to see every warm intro you have to Samit
- Paths you didn't know you had: your email and LinkedIn already hold routes to Samit. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Samit Hirawat, M.D., joined Jeito in 2026 as Strategic Medical Advisor. He was previously Chief Medical Officer and Head of Global Drug Development at Bristol Myers Squibb and Head of Oncology Development at Novartis.
Colleagues at Jeito Capital
Alain Rougon
Chief Financial Officer (external provider, Prodensia) at Jeito Capital
Anastasiya Sybirna
Principal at Jeito Capital
Annette Clancy
Pharma M&A Strategy at Jeito Capital
Arnaud Rousseau
Asset Manager at Ginkgo Advisor Sarl
Benjamin Caillier
Finance Director, Jeito Capital at Jeito Capital
Boris Kere
Compliance Officer at Jeito Capital
Charlotte Formont
Senior Legal Counsel at Jeito Capital
Chloé Morlaàs
Investor Relations Director at Jeito Capital
Frequently asked questions
- Who is Samit Hirawat?
- Samit Hirawat, M.D., joined Jeito in 2026 as Strategic Medical Advisor. He was previously Chief Medical Officer and Head of Global Drug Development at Bristol Myers Squibb and Head of Oncology Development at Novartis.
- Where does Samit Hirawat work?
- Samit Hirawat is Strategic Medical Advisor at Jeito Capital.
About this profile. Compiled from public sources — Jeito Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights